HFP
MRNS

Holistic Financial Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Holistic Financial Partners’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-66
Closed -$1K – 385
2018
Q1 		$1K Hold
66
– – ﹤0.01% 440
2017
Q4 		$2K Buy
+66
New +$1.78K ﹤0.01% 438

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Holistic Financial Partners's MRNS Position: Q2 2018 in Review

Holistic Financial Partners sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2018, closing a stake of 66 shares — an estimated $1K sold.

Holistic Financial Partners first reported a position in MRNS in Q4 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 73 funds tracked by Wall St. Rank hold MRNS as of Q2 2018.

  • Holistic Financial Partners reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2018 after selling out during the quarter.
  • Holistic Financial Partners sold 66 Marinus Pharmaceuticals, Inc shares in Q2 2018, an estimated $1K.
  • Holistic Financial Partners first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 2 quarters.
  • Holistic Financial Partners's Marinus Pharmaceuticals, Inc position peaked at $2K in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2018.

Based on Holistic Financial Partners's 13F filing for Q2 2018, filed 14 Aug 2018.